- Home
- CLRB
as 05-15-2025 9:48am EST
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | FLORHAM PARK |
| Market Cap: | 12.5M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 729.7K |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.77 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.22 - $3.49 | Next Earning Date: | 05-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Cellectar Biosciences Inc. News
CLRB Breaking Stock News: Dive into CLRB Ticker-Specific Updates for Smart Investing
Thomson Reuters StreetEvents
a day ago
Q1 2025 Cellectar Biosciences Inc Earnings Call
GuruFocus.com
a day ago
Cellectar Biosciences Inc (CLRB) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...
GlobeNewswire
2 days ago
Cellectar Biosciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
8 days ago
Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Tuesday, May 13, 2025
GlobeNewswire
15 days ago
Cellectar Announces Plan to Explore Strategic Alternatives
Zacks
a month ago
4 Medical Product Stocks to Buy From a Challenging Industry
Zacks
2 months ago
Is Cellectar Biosciences (CLRB) Stock Outpacing Its Medical Peers This Year?
GuruFocus.com
2 months ago
Cellectar Biosciences Inc (CLRB) Q4 2024 Earnings Call Highlights: Strategic Restructuring and ...
Compare CLRB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLRB Cellectar Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.